Arbutus Biopharma (ABUS) Acquisitions (2015)

Arbutus Biopharma (ABUS) posted Acquisitions of $324000.0 for Q1 2015.

Arbutus Biopharma (ABUS) Acquisitions (2015) Analysis & Trends

Arbutus Biopharma has reported Acquisitions for 1 years, with the latest figure at $324000.0 in Q1 2015.

  • Quarterly Acquisitions changed N/A year-over-year to $324000.0 in Q1 2015, while the trailing twelve-month figure through Dec 2015 was $324000.0 (changed N/A YoY) and the FY2015 annual result came in at $324000.0, changed N/A from the prior year.
  • Acquisitions steadied at $324000.0 in Q1 2015 per ABUS's latest filing.
  • Over five years, Acquisitions peaked at $324000.0 in Q1 2015 and troughed at $324000.0 in Q1 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Arbutus Biopharma 922.95 Mn 830.33 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2015 324,000.00